Leave Your Message

Submit An Free Inquiry

Our medical team will make an evaluation for you, based on the information you provided. This procedure is free of charge.

AI Helps Write
AI Helps Write

Leukemia-da Lymphoblastic ee daran (T-ALL)-09

Bukaanka: Mengmeng

Jinsiga: Dheddig

Da'da: 21 sano jir

Jinsiyadda: Shiinees

Baadhista cudurka: Cudurka Kansarka Lymphoblastic Leukemia (T-ALL)

    Arday jaamacadeed oo lagu magacaabo Mengmeng oo ka soo jeeda Yanjiao, Guizhou, ayaa daawayn wax ku ool ah ka helay BIOOCUS Medical Group.


    Mengmeng, oo dheddig ah, oo 21 jir ah, ayaa la keenay rugtayada bukaan-socodka bishii Juun 22, 2021, iyadoo daal joogto ah qabta. Baaritaanka joogtada ah ee dhiigga ayaa muujiyay in dhuuxa lafaha uu yahay 479×10^9/L. Baaritaanno dheeraad ah oo dhuuxa lafta ah ayaa xaqiijiyay leukemia ba'an oo lymphoblastic ah (nooca unugyada T-cell). Waxay martay laba wareeg oo kiimoterabi ah, laakiin leukemia ma aysan jawaabin, iyadoo MRD (cudurka ugu yar ee haray) uu yahay 56.01%, waxayna sidoo kale lahayd ku lug lahaanshaha leukemia habdhiska neerfaha dhexe.


    Agoosto 13, waxaa la soo ururiyay unugyada unugyada ee iswada, waxaana la siiyay kiimoterabiga. Agoosto 30, Mengmeng waxay heshay unugyada unugyada ee CD7 CAR-T. Laba toddobaad ka dib markii la shubay, baaritaanka dhuuxa lafta wuxuu muujiyay cafis dhammaystiran, taban MRD, iyo xakamaynta leukemia-ga habdhiska neerfaha dhexe. Waxay la kulantay falcelin cytokine sii daaya syndrome (CRS) oo heerka 1aad ah iyada oo aan lahayn falcelin xun oo habdhiska neerfaha dhexe ah.

    107xc

    sharraxaad2

    Submit An Free Inquiry

    Our medical team will make an evaluation for you, based on the information you provided. This procedure is free of charge.

    AI Helps Write